Scientists find a new anti-hepatic fibrosis drug target
HEPA filter effectively reduces airborne respiratory particles generated during vigorous exercise
4 May 2021Detecting rare blood clots was a win, but US vaccine safety system still has gaps
4 May 2021Scientists find a new anti-hepatic fibrosis drug target
Scientists from Russia and Italy studied a new axis of the pathway that prevents the development of liver fibrosis. The role of GILZ protein in curbing the disease progression was shown in a study using mice models and confirmed by clinical data. These findings can be used in the treatment of liver fibrosis in humans. The research was published in the journal Cell Death & Disease.
